Subthalamic Nucleus Stimulation in Parkinson's Disease: 5‐Year Extension Study of a Randomized Trial
Open Access
- 18 October 2021
- journal article
- research article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 9 (1) , 48-59
Abstract
Background: In Parkinson's disease (PD) long‐term motor outcomes of subthalamic nucleus deep brain stimulation (STN‐DBS) are well documented, while comprehensive reports on non‐motor outcomes are fewer and less consistent.Objective: To report motor and non‐motor symptoms after 5‐years of STN‐DBS.Methods: We performed an open 5‐year extension study of a randomized trial that compared intraoperative verification versus mapping of STN using microelectrode recordings. Changes from preoperative to 5‐years of STN‐DBS were evaluated for motor and non‐motor symptoms (MDS‐UPDRS I‐IV), sleep disturbances (PDSS), autonomic symptoms (Scopa‐Aut), quality of life (PDQ‐39) and cognition through a neuropsychological test battery. We evaluated whether any differences between the two randomization groups were still present, and assessed preoperative predictors of physical dependence after 5 years of treatment using logistic regression.Results: We found lasting improvement of off‐medication motor symptoms (total MDS‐UPDRS III, bradykinetic‐rigid symptoms and tremor), on‐medication tremor, motor fluctuations, and sleep disturbances, but reduced performance across all cognitive domains, except verbal memory. Reduction of verbal fluency and executive function was most pronounced the first year and may thus be more directly related to the surgery than worsening in other domains. The group mapped with multiple microelectrode recordings had more improvement of bradykinetic‐rigid symptoms and of PDQ‐39 bodily discomfort sub‐score, but also more reduction in word fluency. Older age was the most important factor associated with physical dependence after 5 years.Conclusion: STN‐DBS offers good long‐term effects, including improved sleep, despite disease progression. STN‐DBS surgery may negatively impact verbal fluency and executive function.Keywords
This publication has 58 references indexed in Scilit:
- Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson’s disease: results from a randomized trialBrain, 2013
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implantsBrain, 2010
- Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trialThe Lancet Neurology, 2010
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled TrialJAMA, 2009
- NEUROPSYCHOLOGICAL EFFECTS AFTER CHRONIC SUBTHALAMIC STIMULATION AND THE TOPOGRAPHY OF THE NUCLEUS IN PARKINSON'S DISEASENeurosurgery, 2007
- SINGLE ELECTRODE AND MULTIPLE ELECTRODE GUIDED ELECTRICAL STIMULATION OF THE SUBTHALAMIC NUCLEUS IN ADVANCED PARKINSON'S DISEASEOperative Neurosurgery, 2007
- Subthalamic Nucleus Stimulation in Parkinson’s Disease Patients Intolerant to LevodopaStereotactic and Functional Neurosurgery, 2007
- Deep brain stimulation: Preoperative issuesMovement Disorders, 2006
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995